Type II Diabetes Flashcards
What are the classes of drugs used to treat type II Diabetes?
Insulin secretagogues, insulin sensitizers, alpha-glucosidase inhibitor, Dipeptidyl Peptidase IV (DPP-IV) inhibitors, Glucagon-like peptide-1 (GLP-1) Mimetic, Sodium-glucose co-transporter 2 (SGLT2) inhibitors
What do Insulin secretagogues do?
Increase basal and/or postprandial insulin levels.
They reduce microalbuminuria
ACTIONS DEPEND OF FUNCTION BETA CELLS
What types of drugs are Insulin secretagogues?
Solfonylureas (1-2 times daily) and Meglitinides (3-4 times daily)
What are the adverse effects of insulin secretagogues?
Weight gain, hypoglycaemia
What is the MOA of Sulfonylureas?
↑ insulin secretion
↓ hepatic clearance of
insulin
↓ Glucagon levels
What drugs are Sulfonylureas?
Glibenclamide & Gliclazide (Long acting 24 hrs)
Glipazide & Glimepiride (Short acting 12-24 hrs)
Where are Sulfonylureas’ metabolised?
In the liver
T or F - Sulfonylureas’ do not cross the placenta
False, they do
What are the CI for Sulfonylureas’?
Hepatic/renal impairment
What are the adverse effects of Sulfonylureas’?
Hypoglycemia, nausea, vomiting, allergic skin reactions,
minor disulfiram-like reactions, headache, cardiotoxicity
What are the drug interactions of Sulfonylureas’?
Aspirin & Sulphonamides potentiate the effects of SUs
Hepatic enzyme inducers, corticosteroids, oral
contraceptives ↓ the effects of SUs
β-blockers mask the signs of hypoglycemia
What are the two types of Meglitinides?
Repaglinide and Nateglanide
T or F - Meglitinides have a slow onset and long duration of action?
False. They have a rapid onset and are short acting
What is the MOA of Meglitinides?
Bind to ATP-dependent K+ channels,
causing insulin release
What drugs can Meglitinides be combined with?
metformin or thiazolidinediones
What are the adverse effects of Meglitinides?
Hypoglycemia
Upper respiratory tract infections
Weight gain
Bronchitis
Headache
What drugs are Thiazolidinediones?
Rosiglitazone (withdrawn) and Pioglitazone
What is the MOA of Thiazolidinediones?
Agonist at peroxisome proliferator-activated receptor – γ (PPARγ). Induces insulin genes
What are the therapeutic uses of Thiazolidinediones?
Monotherapy
With Sulfonylureas
With Metformin
With injected insulin